JAKARTA: Indonesia signed an agreement with China’s Sinovac Biotech Ltd for 50 million doses of a Covid-19 vaccine concentrate that will allow state-owned PT Bio Farma to produce doses locally.
Sinovac would ship the concentrate in five equal stages between November and March, vaccine maker Bio Farma said in a statement. Beijing-based Sinovac also granted priority access for bulk supply to Indonesia until the end of 2021.
